PGY2 Investigational Drug and Research

Introduction

The PGY-2 Investigational Drug and Research Pharmacy residency program at UTSW is a one-year post-graduate training program designed to provide an opportunity for the residents to develop strong clinical foundation, knowledge, leadership skills and experience to specialize in clinical research and investigation drug services. 

Purpose

PGY-2 pharmacy residency program will provide residents with opportunities to function as independent practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings.  Residents who successfully complete the program will be prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.


Pre-ASHP Midyear Information Sessions

Thank you for your interest. We will be completing information sessions for prospective applicants. These sessions will provide opportunities to learn about the program and meet with UT Southwestern leadership. Three dates are being offered: November 15, November 22, December 1, December 2 at 5-6PM CST

UTSW PGY2 IDR Sign Up for Information Session

Interview Sessions

UT Southwestern PGY2 Investigational Drug and Research program will offer 30-minute one-on-one virtual sessions for prospective PGY1 residents to connect with our program leadership (Residency Program Director and Coordinator) and learn more about the program before our application deadline. Sign up via the link below; please only sign up for one time slot. Following sign-up, a Teams meeting link will be sent to the email provided. Interviews will take place December 6 – December 9 from 7 a.m. – 4 p.m. CT (Tuesday, December 7, will be from 1 – 4 p.m. CT).

Sign Up for Interview Session

Rotations

Residents will gain experience and training in the following clinical service areas:

  • Orientation
  • Investigational Drug Service Pharmacy Leadership
  • Investigational Drug Service Operations (Oncology)
  • Investigational Drug Service Operations (Non-oncology; ambulatory)
  • Clinical Patient Care
  • Phase 1 Oncology
  • Hematology-Oncology
  • Acute Care
  • Ambulatory
  • Clinical Trial Office (Oncology)
  • Research Quality, Medication Safety and Regulatory Compliance

Elective Rotations:

  • Drug Development – Clinical Pharmacology
  • Clinical Trial Office (Non-oncology)
  • Ambulatory Clinical Research (Non-oncology)
  • Clinical Trial Development and Support

Longitudinal Expectations

  • Clinical research study management; Institutional Review Board
  • Staff in investigational drug service (equates to every third weekend)
  • Major research project
  • Medication Use Evaluation
  • Precept PGY-1 and students

Program Expectations

  • ACPE-accredited CE presentation
  • Major research project and manuscript
  • Present major research project at a regional or national meeting

Contact Information

Christine Hong, Pharm.D. MBA, BCOP
Residency Program Director
Director of Pharmacy, Oncology and Investigational Drug Services
Email: Christine.Hong@utsouthwestern.edu

Stefanie Conley, Pharm.D. BCOP
Residency Program Coordinator
Clinical Pharmacy Coordinator, Oncology Investigational Drug Services
Email: Stefanie.Conley@utsouthwestern.edu

Program Length

12 months, beginning in July

Available Positions

One new resident each year

Applying to the Program

Requirements

  • Graduation from an ACPE-accredited PharmD Degree program
  • Completion from ASHP-accredited PGY-1 program
  • Eligibility for Texas licensure
  • Virtual or Formal Interview 

Process

  • Applicants must register for the ASHP Resident Matching Program and complete online application via Pharmacy Online Residency Centralized Application Service (PhORCAS) at https://portal.phorcas.org/
  • Anticipated application deadline of January 3, 2022

Salary and Benefits

  • Classified as a full-time employee of UT Southwestern Medical Center
  • Paid vacation/ holiday leave
  • Comprehensive benefits package that includes medical and life insurance
  • Travel funding for conferences